The number of common ophthalmic procedures among Medicare beneficiaries overall declined by 17.9% during the COVID-19 pandemic, according to a report published Thursday in JAMA Ophthalmology.
In this Healio Video Perspective from Retina 2025, Allen C. Ho, MD, discusses the growing promise of optogenetic therapy in treating patients with retinal disease.
In this Healio Video Perspective from Hawaiian Eye 2025, Jason Bacharach, MD, of North Bay Eye Associates, shares data on an aceclidine-based presbyopia-correcting eye drop from Lenz Therapeutics.